{
}
Evenflow, a marketplace aggregator founded by former Uber executives Utsav Agarwal and Pulkit Chhabra, has secured $5 million in its Series A funding round, bringing its total funding to nearly $14 million. The investment, led by Venture Catalysts and angel investors, will be used to expand operations and enhance profitability across its portfolio, which includes brands like Xtrim, Yogarise, and BabyPro.
Alvotech has appointed Dr. Balaji V. Prasad as Chief Strategy Officer, bringing 25 years of pharmaceutical industry experience, including roles at Barclays and Goldman Sachs. Dr. Prasad, who holds an MD and an MBA, aims to leverage his expertise to expand affordable biologics globally, enhancing value for patients and investors. Alvotech focuses on developing biosimilar medicines and has a pipeline of candidates targeting various diseases.
Dr. Reddy's Laboratories, a global pharmaceutical company, reported a 404.9% increase in stock holdings by PNC Financial Services Group during the fourth quarter, now owning 38,644 shares valued at $610,000. The company has a market cap of $11.15 billion and a current price of $13.36 per share, with analysts maintaining a Moderate Buy rating, though some suggest alternative stocks may offer better investment opportunities. Recent earnings showed a slight beat with $0.20 EPS, exceeding estimates, while brokerages have adjusted ratings, reflecting mixed sentiments in the market.
The semaglutides market is projected to grow from $20.54 billion in 2023 to $36.87 billion by 2028, driven by rising diabetes prevalence and increased demand for effective treatments. Key players are innovating with GLP-1 receptor analogues and oral formulations to enhance patient adherence and reduce side effects. North America leads the market, while Asia-Pacific is expected to be the fastest-growing region.
The Global Bisoprolol Fumarate market is projected to grow from USD 1.3 billion in 2023 to USD 2.0 billion by 2032, with a CAGR of 7%. This medication, primarily used for hypertension and heart-related conditions, is expected to see increased demand driven by regulatory changes and market dynamics across various regions, particularly in Europe and Asia-Pacific. Key players include Merck, Pfizer, and Novartis, with a focus on understanding market trends and competitive strategies.
India's "Pharmaceuticals Mission" aims to boost generic production, with simple generics leading the market due to cost-effectiveness and ease of manufacturing. Cardiovascular diseases drive demand, while small molecules dominate product types. Retail pharmacies remain the preferred distribution channel, and key players like Cipla and Teva are expanding their offerings.
High Net Worth Individuals (HNIs) and Ultra High Net Worth Individuals (UHNWIs) in India are diversifying their investments across various asset classes, focusing on equities, real estate, and alternative investments. Key sectors attracting attention include technology, pharmaceuticals, consumer goods, green energy, and financials, driven by urbanization and demand for quality properties. These investors are increasingly sophisticated, seeking high-return and impact-driven opportunities through personalized wealth management solutions.
The Q2 earnings season for FY25 is underway, with major companies like Apollo Hospitals, Kansai Nerolac Paints, and Trident set to release their results. While many firms have reported, the overall corporate earnings scorecard has been weak, with only 62% meeting or exceeding profit expectations, particularly in the consumption sector. Notably, GAIL's earnings missed expectations due to lower gas trading margins, while Power Grid's profit remained flat year-on-year.
Dr. Reddy’s Laboratories reported a strong Q2FY25 performance, with US sales growing 15.6% YoY to USD 445 million, driven by gRevlimid and a robust vaccine portfolio in India. The company’s outlook remains positive, supported by recent acquisitions and new product launches, prompting a HOLD rating with a target price of INR 1,270.
Dr. Reddy's Laboratories reported its highest-ever quarterly revenue in Q2, yet brokerages maintain a neutral stance due to a lack of a strong drug pipeline. Despite increased R&D spending on biosimilars and generics, firms like Nuvama and Jefferies express concerns over the absence of major product launches, leading to reduced stock ratings and target prices of Rs 1,215 and Rs 1,130, respectively.
Dr. Reddy's Laboratories Limited
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Evenflow secures 5 million dollars in series A funding round
06:50 02.04.2025
Alvotech appoints Dr Balaji V Prasad as Chief Strategy Officer
Barclays PLC
Dr. Reddy's Laboratories Limited
The Goldman Sachs Group, Inc.
Jamp Pharma Corporation SA
Cipla Limited
STADA Arzneimittel AG
Fuji Pharma Co., Ltd.
ISL
Róbert Wessman
Benedikt Stefansson
Balaji Prasad
Show more
09:30 27.03.2025
dr reddy's laboratories sees significant institutional investment amid mixed analyst ratings
08:32 19.03.2025
semaglutides market projected to reach 36.87 billion by 2028
United States Dollar
Adocia SA
Sanofi SA
Eli Lilly and Company
Roche Holding AG
Pfizer Inc.
Merck & Co., Inc.
Dr. Reddy's Laboratories Limited
Boehringer Ingelheim International GmbH
Glaxosmithkline plc
Takeda Pharmaceutical Company Limited
AbbVie Inc.
Novartis International AG
Bristol-Myers Squibb Company
Novo Nordisk A/S
Cipla Limited
Biocon Limited
Teva Pharmaceutical Industries Ltd
AstraZeneca PLC
Amgen Inc.
ITA
IND
FRA
IDN
CAN
ESP
BRA
USA
RUS
CHN
DEU
AUS
JPN
GBR
KOR
Show more
10:12 06.01.2025
global bisoprolol fumarate market poised for significant growth through 2032
United States Dollar
Merck & Co., Inc.
Amgen Inc.
Alkem Laboratories Limited
Mylan Pharmaceuticals Inc.
Aurobindo Pharma Limited
Teva Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Limited
Glenmark Pharmaceuticals Limited
CIPLA LTD
Sandoz Group AG
Pfizer Inc.
Bayer AG
Hikma Pharmaceuticals PLC
AstraZeneca PLC
Novartis AG
Torrent Pharmaceuticals Limited
Sanofi
IND
ROU
BEL
HUN
DNK
POL
IDN
SGP
ARE
BRA
ZAF
FRA
THA
MEX
CZE
GBR
CHL
AUT
SAU
SWE
NOR
NLD
USA
ARG
MYS
SVK
CAN
NZL
LKA
JPN
DEU
RUS
KOR
CHN
VNM
Nidhi Bhavsar
Show more
13:09 16.12.2024
Global Generic Pharmaceuticals Market Sees Growth in Simple Generics and Biosimilars
United States Dollar
Euro
Fresenius Kabi AG
Sanofi
Aspen Pharmacare Holdings Ltd
Sun Pharmaceuticals, Ltd.
Aurobindo Pharma Limited
Glenmark Pharmaceuticals Limited
Pfizer Inc.
Lupin Limited
Dr. Reddy's Laboratories Limited
Zydus Lifesciences Limited
Teva Pharmaceuticals, Inc.
Viatris Inc.
Novartis AG
Hikma
Cipla Limited
IND
USA
Show more
16:30 04.12.2024
investment trends among high net worth individuals in india
United States Dollar
Dr. Reddy's Laboratories Limited
Zomato Limited
Dabur India Ltd.
Adani Green Energy Limited
HDFC Bank Ltd.
Infosys Limited
Tata Consultancy Services Limited
ICICI Bank Limited
Hindustan Unilever Limited
Cipla Limited
IND
Dabur
Hindustan Unilever
Cipla
Dr. Reddy's Laboratories
Adani Green Energy
Show more
05:30 09.11.2024
quarterly earnings reports reveal mixed results across various sectors
United States Dollar
Indian Rupee
Havells India Limited
HCL Technologies Limited
Raymond
L&T
Apollo Hospitals Enterprise Limited
Dabur India Limited
Sonata Software Limited
Dr. Reddy's Laboratories Limited
HDFC Bank Limited
Bata India Limited
Bhel (BAP Unit) EPF Trust
Kansai Nerolac Paints Limited
Axis Bank Limited
PVR INOX Limited
Titan Company Limited
Gujarat Pipavav Port Limited
Adani Enterprises Limited
Bharti Airtel Limited
Nestlé India Limited
Piramal Pharma Limited
Marico Limited
Power Grid Corporation of India Limited
TeamLease Services Limited
Spencer's Retail Limited
Reliance Industries Limited
Exide Industries Limited
DR Reddy's Laboratoire Ltd.
Punjab National Bank
Tech Mahindra Limited
JK Lakshmi Cement Limited
GAIL (India) Limited
Berger Paints India Limited
TVS Motor Company Limited
Coal India Limited
HUL
Bajaj Auto Limited
Gujarat Gas Limited
Gland Pharma Limited
Trident Limited
Indian Railway Catering & Tourism Corporation Limited
Jindal Steel & Power Limited
Zomato Limited
Adani Wilmar Limited
Paytm Money Ltd.
Kirloskar Ferrous Industries Limited
Mankind Pharma Limited
Dhanuka Agritech Limited
Pricol Limited
Infosys Limited
KPI Green Energy Limited
Granules India Limited
Tata Consultancy Services Limited
Avalon Technologies Limited
Procter & Gamble Health Limited
Wipro Limited
Blue Star Limited
ITC Limited
IND
Donald Trump
Vir S Advani
Show more
17:12 06.11.2024
Dr Reddy's Laboratories maintains hold rating with target price of 1270
09:04 06.11.2024
brokerages maintain neutral stance on dr reddys labs amid pipeline concerns
04:09 06.11.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People: